Capture Threshold and Output Voltage in Aveir VR Leadless Pacemaker

Capture Threshold

The capture threshold in the Aveir VR is the minimum electrical energy required to consistently depolarize the myocardium and produce a mechanical contraction. Key points:

Normal values:

• Typically measured at implant: ≤1.0V @ 0.24ms is considered acceptable
• Chronic threshold target: <2.0V @ 0.24ms during follow-up
• The device uses autocapture algorithms to continuously monitor and adapt

Measurement considerations:

• The Aveir VR's helix fixation mechanism can affect acute thresholds
• Micro-dislodgments or changes in contact can elevate thresholds
• Lead maturation typically occurs over 4-6 weeks, with potential threshold rise
• Nocturnal variations can occur due to changes in autonomic tone and tissue impedance

Output Voltage

The Aveir VR uses programmable output settings to ensure reliable capture with safety margin:

Programmable parameters:

• Voltage amplitude: Typically programmable from 0.5V to 5.0V
• Pulse width: Usually 0.24ms or 0.4ms standard options
• Safety margin: Generally programmed at 2-3× the measured threshold

Automatic management:

The Aveir VR features an autocapture algorithm that:

• Continuously verifies capture on a beat-to-beat basis
• Automatically adjusts output to maintain capture with minimal safety margin
• Reduces unnecessary energy output to extend battery longevity
• Typically maintains output at threshold + 0.5V when functioning properly

Battery longevity considerations:

• Higher output voltages drain battery faster
• Expected longevity: 7-12 years depending on pacing burden and output settings
• Optimizing output voltage (using autocapture) is crucial for maximizing device longevity

The Core Relationship

Output voltage must exceed capture threshold to reliably pace the heart. This relationship determines:

• Standard practice: 2:1 safety margin (output is 2× threshold)
• Example: If threshold = 1.0V, program output to 2.0V

Why This Matters

Too low output voltage (insufficient margin):

• Intermittent capture loss
• Particularly problematic during:
  • Sleep (when thresholds may rise)
  • Exercise (increased sympathetic tone)
  • Lead maturation phase
  • Metabolic changes

Too high output voltage (excessive margin):

• Unnecessary battery drain
• Shortened device longevity
• No clinical benefit beyond reliable capture

The Aveir VR's Optimization

The autocapture feature continuously adjusts this relationship:

1. Measures threshold automatically (usually daily or more frequently)
2. Adjusts output voltage to maintain minimal safe margin
3. Verifies capture beat-by-beat with evoked response sensing
4. Adapts dynamically to physiologic changes

Clinical Significance

The strength-duration curve also plays a role - longer pulse widths can capture at lower voltages, but the Aveir VR typically uses fixed pulse widths (0.24ms), so voltage adjustment is the primary method for maintaining the threshold-to-output relationship.

Immediate Concerns

High capture threshold (2.75V @ 0.24ms):

• This is significantly elevated compared to optimal values (<1.0V at implant, <2.0V chronically)
• Suggests potential issues with:
  • Lead position/contact - suboptimal myocardial interface
  • Micro-dislodgment - helix may have partially withdrawn
  • Fibrosis/inflammation - excessive tissue reaction at fixation site
  • Perforation risk - if helix penetrated too deeply
  • Exit block - though less common with modern leads

Narrow safety margin:

Battery Longevity Impact

With these parameters:

• Maximum output voltage (4.0V) likely being used continuously
• High pacing energy consumption
• Significantly reduced device longevity - possibly 3-5 years instead of 7-12 years
• May require earlier device replacement

Clinical Recommendations

Immediate actions:

1. Verify measurements - repeat threshold testing to confirm accuracy
2. Check device diagnostics:
   • Impedance trends (sudden changes suggest dislodgment)
   • Pacing burden percentage
   • Battery voltage status
   • Any autocapture failures logged
3. Imaging evaluation:
   • Chest X-ray to assess device position
   • Compare with immediate post-implant films
   • Look for migration or rotation

Clinical decision-making:

Risk-benefit analysis:

• Patient is pacemaker-dependent → immediate safety priority
• NOT pacemaker-dependent → can be more conservative with monitoring

Bottom Line